Loperamid APTEO MED

GIF decision: Withdrawal from market, Marketing prohibition

What does this decision mean?

  • Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.
  • Zakaz wprowadzania — Selected batches are subject to a marketing prohibition — the product cannot be distributed to pharmacies.

A stability test showed the active substance content below the lower specification limit, meaning the batch does not meet quality requirements and may not provide the intended therapeutic effect. Potential effects: lack of antidiarrheal efficacy, possible worsening of symptoms and complications of the underlying disease.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Loperamid APTEO MED
Risk Level
High
Manufacturer
Synoptis Pharma Sp. z o.o. z siedzibą w Warszawie
Batch Number
IJW024001
Notice Date
09.02.2026
View official statement

Related

Other Notices